Alyeska Investment Group
AMRX icon

Alyeska Investment Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Alyeska Investment Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-267,475
Closed -$1.92M – 402
2019
Q2 		$1.92M Sell
267,475
-127,881
-32% -$1.31M 0.02% 323
2019
Q1 		$5.6M Buy
395,356
+153,112
+63% +$2.02M 0.07% 216
2018
Q4 		$3.28M Sell
242,244
-383,178
-61% -$6.9M 0.05% 256
2018
Q3 		$13.9M Buy
625,422
+447,982
+252% +$9.43M 0.15% 158
2018
Q2 		$2.91M Buy
+177,440
New +$3.11M 0.03% 325

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Alyeska Investment Group's AMRX Position: Q3 2019 in Review

Alyeska Investment Group sold out of Amneal Pharmaceuticals (AMRX) in Q3 2019, closing a stake of 267,475 shares — an estimated $1.92M sold.

Alyeska Investment Group first reported a position in AMRX in Q2 2018 and held it in 5 quarters. The position peaked at $13.9M in Q3 2018. 121 funds tracked by Wall St. Rank hold AMRX as of Q3 2019.

  • Alyeska Investment Group reported no remaining Amneal Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 267,475 Amneal Pharmaceuticals shares in Q3 2019, an estimated $1.92M.
  • Alyeska Investment Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • Alyeska Investment Group's Amneal Pharmaceuticals position peaked at $13.9M in Q3 2018.
  • 121 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.